Daxor ROE 2010-2011 | DXR
Current and historical return on equity (ROE) values for Daxor (DXR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Daxor ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2011-12-31 | $-0.01B | $0.04B | -14.46% |
| 2011-09-30 | $-0.00B | $0.04B | -6.78% |
| 2011-06-30 | $0.00B | $0.05B | 8.56% |
| 2011-03-31 | $0.00B | $0.05B | 8.70% |
| 2010-12-31 | $0.01B | $0.05B | 10.81% |
| 2010-09-30 | $0.00B | $0.05B | 4.30% |
| 2010-06-30 | $0.00B | $0.04B | 4.26% |
| 2010-03-31 | $0.01B | $0.05B | 16.84% |
| 2009-12-31 | $0.01B | $0.05B | 13.71% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.046B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $16.867B | 10.20 |
| Quest Diagnostics (DGX) | United States | $15.351B | 15.86 |
| DaVita (DVA) | United States | $12.191B | 16.59 |
| Chemed (CHE) | United States | $8.599B | 26.65 |
| Encompass Health (EHC) | United States | $8.350B | 21.49 |
| Elanco Animal Health (ELAN) | United States | $6.502B | 14.79 |
| Option Care Health (OPCH) | United States | $5.195B | 19.66 |
| RadNet (RDNT) | United States | $3.584B | 97.00 |
| Amedisys (AMED) | United States | $3.008B | 21.31 |
| LifeStance Health (LFST) | United States | $2.362B | 0.00 |
| Astrana Health (ASTH) | United States | $2.081B | 25.98 |
| Addus HomeCare (ADUS) | United States | $1.574B | 23.92 |
| U.S Physical Therapy (USPH) | United States | $1.530B | 39.65 |
| Pennant (PNTG) | United States | $0.628B | 36.68 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.433B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.331B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.027B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.018B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.013B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.012B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |